AMRZ Earnings & Financial Statements
Amrize Ltd
$41.87
-$0.78(-1.83%)
67
Overall
100
Value
50
Tech
52
Quality
Market Cap
$22.29B
Volume
2.93M
52W Range
$35.79 - $65.94
Target Price
$48.32
AMRZ earnings and financial statements: Amrize Ltd's income statement, balance sheet and cash flow statement, annual and quarterly.
AMRZ Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $11.81B | $11.70B | $11.68B |
| Cost of revenue | $8.78B | $8.63B | $8.91B |
| Operating income | $1.91B | $2.13B | $1.83B |
| EBITDA | $2.81B | $3.15B | $2.70B |
| Net income | $1.19B | $1.38B | $956.00M |
| EPS (diluted) | $2.14 | $2.30 | - |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $24.25B | $23.80B | $23.05B |
| Total liabilities | $10.99B | $13.89B | $13.84B |
| Shareholders’ equity | $13.26B | -$606.00M | $9.20B |
| Cash and equivalents | $1.92B | $1.58B | $1.11B |
| Long-term debt | $5.76B | $1.37B | $1.31B |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | $2.21B | $2.28B | $2.04B |
| Capital expenditure | -$788.00M | - | - |
| Free cash flow | $1.42B | $1.70B | $1.46B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMRZ | $41.87 | -1.8% | 2.93M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |